Anthropic’s IPO Filing Shows $16B Revenue and $80.7M Loss

By James Calloway

Anthropic, the maker of Claude, reported more than $16 billion in revenue and an $80.7 million first-half net loss in a Monday S-1 filing for a Nasdaq initial public offering (IPO) under the ticker ANT. The filing gives prospective investors a financial snapshot through the first half of 2026, alongside risks that include access to adequate computing capacity, intense lab competition and catastrophic AI outcomes.

The Wall Street Journal reported the IPO could come later in November. The S-1 states neither the offering size nor a target valuation; The New York Times reported in August that Anthropic was seeking more than $100 billion at a valuation around $2 trillion. That creates a difficult market test: investors would fund a fast-growing, unprofitable AI company before the terms of that funding become final.

What do the financial figures show?

According to Anthropic, revenue grew to more than $16 billion, up from about $4.5 billion in 2025. The company emphasized its growing enterprise business and disclosed these customer spending levels over the past 12 months:

• More than 11,900 customers spent at least $100,000.
• More than 1,900 spent $1 million or more.
• Roughly 250 spent $10 million or more.

Anthropic had not turned a profit. It posted a net loss of $80.7 million in the first half of 2026, compared with a $13 billion net loss in the same period a year earlier. WIRED’s account does not explain the factors behind that year-over-year change.

Together, the revenue growth and spending tiers give the IPO a commercial foundation. The continuing loss keeps the investment case dependent on further growth and eventual profitability rather than present earnings.

Takeaway: Anthropic has enterprise scale and rapid growth, but its filing still shows a loss.

What remains unsettled about the IPO?

According to the S-1, Anthropic plans to go public on Nasdaq under the ticker ANT. The filing gives no offering size or target valuation.

The Wall Street Journal’s later-November report remains a timing indication, not a prospectus commitment. The New York Times’ August fundraising report likewise remains outside the filing, which leaves both central deal terms unconfirmed.

OpenAI provides a sharp contrast. It filed confidentially for an IPO in the summer. In September, it said it no longer intended to go public this year, citing concerns about the risks AI poses to humanity.

That contrast does not establish that Anthropic has resolved those concerns or secured comparable public-market backing. WIRED described the filing as a developing story, and Anthropic did not immediately respond to WIRED’s request for comment.

Takeaway: The filing establishes listing intent, not final timing, size or valuation.

What risks did Anthropic disclose?

The prospectus says investing in Anthropic stock carries “a high degree of risk.” WIRED noted that companies are expected to report risk factors accurately before describing this list as particularly thorough.

The filing identifies three broad threats:

• Computing access: Anthropic may fail to secure adequate computing capacity.
• Competition: Rival laboratories may intensify competition for customers and technical talent.
• Severe AI outcomes: Advanced AI systems may “pose catastrophic or existential risks to humanity.”

The filing also warns that sophisticated AI could be abused by threat actors to launch cyberattacks and develop novel biological weapons. Authoritarian governments could also use the systems to surveil their citizens, and Anthropic could lose control of the models it develops. WIRED’s report gives no probabilities or timetables for those outcomes.

These disclosures make risk part of the commercial case rather than a separate compliance exercise. They also leave investors without a way to quantify how computing constraints, rival labs or harmful deployments could affect revenue.

Takeaway: Anthropic itself treats computing access, competition and AI misuse as business risks.

How does the safety mission fit the IPO?

Anthropic was founded in 2021 by seven former OpenAI employees who, according to the source, had lost faith in the lab’s ability to develop advanced AI models safely. The company markets itself as highly safety-conscious. Its CEO, Dario Amodei, has repeatedly commented that AI could eliminate scores of jobs and act against human interests.

The filings outline Anthropic’s ambition to develop sophisticated AI models capable of accelerating scientific discovery, curing disease and spurring economic growth. Anthropic wrote: “To build AI is to harness cognition itself, and anything so powerful can be used for ill as well as good.”

Anthropic also recruited investors in unusually direct terms: “The advent of machine intelligence is one of the seminal moments in human history,” Anthropic wrote. “We encourage you, as a prospective owner of our stock, not to think of your purchase in purely transactional terms. We hope you will see it instead as an opportunity to be part of something greater.”

The account WIRED provided includes no model benchmarks, deployment milestones, safety thresholds or control evaluations for those ambitions. The result is a prospectus asking investors to join a public-interest mission while warning that the technology’s development could threaten humanity.

Takeaway: The company asks investors to join a historic mission while warning that AI could threaten humanity.

What could government action change?

The prospectus highlights the volatility of government action. Anthropic specifically cited the Trump Administration’s decision to designate the company as a supply-chain risk.

The filing warns: “While we continue to work with government agencies, we cannot be certain that the resolution of these lawsuits will not adversely affect our ability to sell to government agencies and other customers that sell products and services to the U.S. government, and in turn adversely affect our business, financial condition, and results of operations.”

The filing details provided do not identify the lawsuits, their status, a resolution timetable or the basis for the supply-chain designation. That omission matters because the stated risk extends beyond direct government sales to private companies that sell products and services to the government.

Government policy therefore has two potential commercial effects: it could restrict Anthropic’s direct eligibility for government business, or it could discourage customers whose own revenue depends on government contracts. Neither effect can be sized from the information WIRED cited.

Takeaway: Government policy can become a direct sales constraint, not just a disclosure item.

What should investors watch next?

Three basic questions remain open as the IPO develops. The relevant disclosures are straightforward:

• Whether Anthropic confirms the later-November IPO window reported by The Wall Street Journal.
• How much the company plans to raise and what valuation it ultimately assigns.
• What explains the net loss’s change from $13 billion to $80.7 million.

An amended prospectus could also clarify the lawsuits, the supply-chain designation and the computing capacity needed for Anthropic’s expansion plans. Until then, the company’s reported revenue and enterprise spending remain its strongest evidence of commercial traction.

Takeaway: Amended filings and final offering terms will provide the next test of Anthropic’s claims.